about
DOSY NMR and MALDI-TOF evidence of covalent binding the DNA duplex by trimethylammonium salts of topotecan upon near UV irradiation.Cellular basis of antiproliferative and antitumor activity of the novel camptothecin derivative, gimatecan, in bladder carcinoma models.Down-regulation of adenine nucleotide translocase 3 and its role in camptothecin-induced apoptosis in human hepatoma QGY7703 cells.Assessment of anti-cytogenotoxic effects of quercetin in animals treated with topotecan.The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.A series of alpha-amino acid ester prodrugs of camptothecin: in vitro hydrolysis and A549 human lung carcinoma cell cytotoxicity.Effects of camptothecin and hydroxycamptothecin on insect cell lines Sf21 and IOZCAS-Spex-II.Camptothecin induces apoptosis of human retinoblastoma cells via activation of FOXO1.Upregulation of NOXA by 10-Hydroxycamptothecin plays a key role in inducing fibroblasts apoptosis and reducing epidural fibrosis.A two-step pH-dependent liquid-liquid extraction combined with HPLC-fluorescence method for the determination of 10-hydroxycamptothecin in mouse liver tissue.The Effect of Hydroxycamptothecin on Wound Healing Following Reduction of the Knee Intra-Articular Adhesion in Rabbits.SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study.Sustainable bioproduction of phytochemicals by plant in vitro cultures: anticancer agents
P2860
Q30960052-A701BB1E-5AF4-415E-9251-9B27989CC3A2Q34768288-C92A207B-E715-49DF-B3B2-6FF5275F1FDCQ34911405-83D55B72-18AF-48E3-989A-0FD3E8472810Q35185625-DD1A7104-6D0F-4807-891A-99F81CF3D05AQ36839637-A0E6E3A1-0808-4893-B8D7-633D62989809Q37512130-B42CF92E-BA5B-4051-8DEC-7BD4354CA8DEQ39446577-D61DDF74-D810-4B93-9A06-F029BE6E1D07Q39803115-1FDA0521-96DF-4ADE-A113-FECD6D149C4EQ42043325-07BDD101-F5C1-43CB-A660-811FB4A2C71AQ47929494-319F0640-9887-4EC5-8FBC-D9364D770EB8Q52963428-6244159D-FD85-4BD1-A1C4-6313D85998DBQ55379526-37CAAFC1-0208-4738-B87B-0B66C1237DF0Q56971866-AB7323A2-799B-474F-BD5B-4D729CAD433D
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Camptothecins in clinical development.
@ast
Camptothecins in clinical development.
@en
type
label
Camptothecins in clinical development.
@ast
Camptothecins in clinical development.
@en
prefLabel
Camptothecins in clinical development.
@ast
Camptothecins in clinical development.
@en
P2860
P1476
Camptothecins in clinical development.
@en
P2093
Franco Zunino
Graziella Pratesi
P2860
P304
P356
10.1517/13543784.13.3.269
P407
P577
2004-03-01T00:00:00Z